Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Sep 3, 2010

Premium

Norrie Russell has been appointed president of Gene Logic, an Ocimum Biosolutions company, Ocimum announced this week.

Prior to joining Gene Logic, Russell held leadership roles with NovaRx, Invitrogen, Aviva Biosciences, and Lynx Therapeutics. He also worked at AstraZeneca, where he was global head of biological science and technology.

Russell holds a PhD in physiology from Glasgow University in Scotland.


San Francisco-based molecular diagnostics startup MLC Dx recently disclosed several company executives in a filing with the US Securities and Exchange Commission.

Thomas Willis is the company's president and CEO. Prior to that, he worked at Affymetrix, following the firm’s acquisition of ParAllele BioScience, a company he co-founded and where he served as CEO and later as chief scientific officer.

Malek Faham is the firm's CSO. Previously, he was vice president of oncology technology research at Affymetrix, and before that, director of research at ParAllele, which he also co-founded.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.